FDA Approves New Animal Drug for General Anesthesia in Dogs

Summary

The US Food and Drug Administration (FDA) is updating its animal drug regulations to reflect the approval of a new animal drug application (NADA) submitted by pharmaceutical company Abbott Laboratories. The NADA allows for the use of sevoflurane as an inhalant for general anesthesia in dogs.